🇺🇸 FDA
Patent

US 11166949

NURR1 activation in the treatment of metabolic disorders and as an exercise mimetic

granted A61KA61K31/437A61K31/47

Quick answer

US patent 11166949 (NURR1 activation in the treatment of metabolic disorders and as an exercise mimetic) held by The Board of Regents of the University of Texas System expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/437, A61K31/47, A61K31/4706, A61K38/2264